Renaissance Technologies - STEMLINE THERAPEUTICS INC ownership

STEMLINE THERAPEUTICS INC's ticker is STML and the CUSIP is 85858C107. A total of 74 filers reported holding STEMLINE THERAPEUTICS INC in Q4 2016. The put-call ratio across all filers is 1.21 and the average weighting 0.1%.

Quarter-by-quarter ownership
Renaissance Technologies ownership history of STEMLINE THERAPEUTICS INC
ValueSharesWeighting
Q1 2020$766,000
+9.3%
158,213
+141.5%
0.00%0.0%
Q4 2016$701,000
+6.7%
65,500
+7.9%
0.00%0.0%
Q3 2016$657,000
+83.5%
60,700
+14.7%
0.00%0.0%
Q2 2016$358,000
-3.0%
52,900
-33.1%
0.00%0.0%
Q1 2016$369,000
-14.8%
79,100
+15.3%
0.00%0.0%
Q4 2015$433,000
-65.0%
68,600
-30.9%
0.00%
-66.7%
Q3 2014$1,237,000
-16.5%
99,300
-1.7%
0.00%0.0%
Q2 2014$1,482,000101,0520.00%
Other shareholders

There were no reported owners of STEMLINE THERAPEUTICS INC in Q4 2016.

NameSharesValueWeighting ↓
View complete list of STEMLINE THERAPEUTICS INC shareholders